These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3051354)

  • 1. Tumor necrosis factor.
    Old LJ
    Sci Am; 1988 May; 258(5):59-60, 69-75. PubMed ID: 3051354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor and cancer treatment: a historical review and perspectives.
    Terlikowski SJ
    Rocz Akad Med Bialymst; 2001; 46():5-18. PubMed ID: 11780579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective.
    Wiemann B; Starnes CO
    Pharmacol Ther; 1994; 64(3):529-64. PubMed ID: 7724661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection and cancer.
    Haux J
    Lancet; 2001 Jul; 358(9276):155-6. PubMed ID: 11469250
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine anniversary: TNF trailblazers five centuries apart.
    Libert C
    Nature; 2015 Jul; 523(7559):158. PubMed ID: 26156365
    [No Abstract]   [Full Text] [Related]  

  • 6. Calling cells to arms.
    Elert E
    Nature; 2013 Dec; 504(7480):S2-3. PubMed ID: 24352361
    [No Abstract]   [Full Text] [Related]  

  • 7. Coley's toxin: historical perspective.
    Bickels J; Kollender Y; Merinsky O; Meller I
    Isr Med Assoc J; 2002 Jun; 4(6):471-2. PubMed ID: 12073431
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour necrosis factor: clinical relevance.
    Jones AL; Selby P
    Cancer Surv; 1989; 8(4):817-36. PubMed ID: 2701729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.
    Larrick JW; Kunkel SL
    Pharm Res; 1988 Mar; 5(3):129-39. PubMed ID: 3072553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?
    Zacharski LR; Sukhatme VP
    J Thromb Haemost; 2005 Mar; 3(3):424-7. PubMed ID: 15748226
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical application of anticancer cytokines].
    Watanabe N
    Nihon Rinsho; 1992 Aug; 50(8):1973-7. PubMed ID: 1279241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paradox of pro-inflammatory cytokines in cancer.
    Dinarello CA
    Cancer Metastasis Rev; 2006 Sep; 25(3):307-13. PubMed ID: 17029030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous regression: a hidden treasure buried in time.
    Hoption Cann SA; van Netten JP; van Netten C; Glover DW
    Med Hypotheses; 2002 Feb; 58(2):115-9. PubMed ID: 11812185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor/cachectin: biology and relevance to disease.
    Das UN
    J Assoc Physicians India; 1991 Feb; 39(2):201-4. PubMed ID: 1885487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy and molecular immunology unite to give new life to cancer immunotherapy.
    Ando D
    Mol Ther; 2002 Jun; 5(6):665-7. PubMed ID: 12027549
    [No Abstract]   [Full Text] [Related]  

  • 16. [Not Available].
    Fridman WH
    Bull Cancer; 2016 Nov; 103 Suppl 1():S122-S126. PubMed ID: 28057174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer).
    Guo ZS
    BMC Cancer; 2018 Nov; 18(1):1086. PubMed ID: 30415640
    [No Abstract]   [Full Text] [Related]  

  • 18. The study of innate immunity in Japan: a historical perspective.
    Kaisho T; Takeda K
    Int Immunol; 2009 Apr; 21(4):313-6. PubMed ID: 19246553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology.
    Rockett KA; Awburn MM; Rockett EJ; Clark IA
    Am J Trop Med Hyg; 1994 Jun; 50(6):735-42. PubMed ID: 8024067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.
    Kianmanesh A; Hackett NR; Lee JM; Kikuchi T; Korst RJ; Crystal RG
    Hum Gene Ther; 2001 Nov; 12(17):2035-49. PubMed ID: 11747595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.